COMPARISON OF ONCE-DAILY VERSUS TWICE-DAILY COMBINATION ANTIRETROVIRAL THERAPY IN TREATMENT-NAÏVE PATIENTS: RESULTS OF AIDS CLINICAL TRIALS GROUP (ACTG) A5073, A 48-WEEK RANDOMIZED CONTROLLED TRIAL

BACKGROUND: Dosing frequency is an important determinant of regimen effectiveness. METHODS: To compare efficacy of once-daily (QD) versus twice-daily (BID) antiretroviral therapy, we randomized HIV-1 positive, treatment-naïve, patients to lopinavir/ritonavir (LPV/r) 400/100 mg BID (n=160) or LPV/r 8...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Flexner, Charles, Tierney, Camlin, Gross, Robert, Andrade, Adriana, Lalama, Christina, Eshleman, Susan H., Aberg, Judith, Sanne, Ian, Parsons, Teresa, Kashuba, Angela, Rosenkranz, Susan L., Kmack, Anne, Ferguson, Elaine, Dehlinger, Marjorie, Mildvan, Donna
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2833234/
https://ncbi.nlm.nih.gov/pubmed/20192725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/651118
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados